Latest / Medical Device Global Market Access
FDA Discussion Paper on Generative AI in Medical Devices: Feedback Deadline and Key Considerations
This episode details the US FDA's discussion paper on regulating medical devices incorporating Generative Artificial Intelligence (GenAI), released on August 18, 2026. We cover the key areas where the FDA is seeking input, including risk assessment, premarket evaluation, and postmarket monitoring for GenAI-enabled devices. We also emphasize the critical October 19, 2026, deadline for submitting feedback and provide practical steps for manufacturers to prepare and respond. Key Questions: - What is the FDA's new discussion paper on Generative AI in medical devices? - Why is the FDA seeking…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.